Gene Expression Analysis of Early Stage Changes in Pancreatic Cancer by KrasG12D Transfer in Pancreatic Progenitor-Like Cells.

IF 1.9 4区 医学 Q3 ONCOLOGY
Cancer Investigation Pub Date : 2025-07-01 Epub Date: 2025-08-06 DOI:10.1080/07357907.2025.2543849
Eiji Yamato
{"title":"Gene Expression Analysis of Early Stage Changes in Pancreatic Cancer by <i>Kras<sup>G12D</sup></i> Transfer in Pancreatic Progenitor-Like Cells.","authors":"Eiji Yamato","doi":"10.1080/07357907.2025.2543849","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to elucidate the function of <i>Kras</i>, which is involved in the development and progression of pancreatic cancer.</p><p><strong>Methods: </strong>We have previously isolated pancreas-derived cells from mice and induced genes expressed in pancreatic ducts and exocrine and endocrine cells by expressing transcription factor genes and a plasmid expressing polyoma ori to create cells with stable foreign gene expression. Comprehensive gene analysis was used to analyze the function of <i>Kras</i> by introducing wild-type <i>Kras</i> and mutant <i>Kras</i> into these cells.</p><p><strong>Results: </strong>No changes in cell morphology were observed with wild-type Kras expression, but expression of mutant <i>Kras</i> led to cystic changes. Mutant <i>Kras</i> gene transfer induced the expression of <i>Mus5ac</i> and <i>Cck</i> genes. Gene expression in these cells was detected by microarray analysis, and comparison of gene profiles showed that the genes promoted amoeboid cell assembly and immunosuppression.</p><p><strong>Conclusion: </strong>The use of these cells will facilitate screening of drugs that block <i>Kras</i> function and elucidate how <i>Kras</i> induces pancreatic cancer.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"467-476"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07357907.2025.2543849","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The aim of this study is to elucidate the function of Kras, which is involved in the development and progression of pancreatic cancer.

Methods: We have previously isolated pancreas-derived cells from mice and induced genes expressed in pancreatic ducts and exocrine and endocrine cells by expressing transcription factor genes and a plasmid expressing polyoma ori to create cells with stable foreign gene expression. Comprehensive gene analysis was used to analyze the function of Kras by introducing wild-type Kras and mutant Kras into these cells.

Results: No changes in cell morphology were observed with wild-type Kras expression, but expression of mutant Kras led to cystic changes. Mutant Kras gene transfer induced the expression of Mus5ac and Cck genes. Gene expression in these cells was detected by microarray analysis, and comparison of gene profiles showed that the genes promoted amoeboid cell assembly and immunosuppression.

Conclusion: The use of these cells will facilitate screening of drugs that block Kras function and elucidate how Kras induces pancreatic cancer.

KrasG12D在胰腺祖样细胞中转移胰腺癌早期变化的基因表达分析
目的:探讨Kras基因在胰腺癌发生发展过程中的作用。方法:我们已经从小鼠身上分离出胰腺源性细胞,通过表达转录因子基因和表达多瘤基因的质粒,诱导胰腺管和外分泌和内分泌细胞中表达的基因,从而产生外源基因稳定表达的细胞。通过将野生型和突变型Kras导入这些细胞,采用综合基因分析方法分析Kras的功能。结果:Kras野生型表达对细胞形态无影响,而Kras突变型表达可引起囊性改变。Kras突变体基因转移诱导了Mus5ac和Cck基因的表达。通过芯片分析检测这些细胞中的基因表达,基因谱比较显示这些基因促进阿米巴细胞组装和免疫抑制。结论:利用这些细胞有助于筛选阻断Kras功能的药物,阐明Kras诱导胰腺癌的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Investigation
Cancer Investigation 医学-肿瘤学
CiteScore
3.80
自引率
4.20%
发文量
71
审稿时长
8.5 months
期刊介绍: Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信